OUR MISSION is to serve pharmaceutical clients that provide cures and treatments for gastro-entrological diseases including: gallstones, PBC, PSC and NASH.
ICE Group announces the acquisition of New Zealand Pharmaceuticals
Reggio Emilia, August 17th, 2020
ICE Group is proud to announce the acquisition of New Zealand Pharmaceuticals (“NZP”), a primary developer and manufacturer of biopharmaceutical products specialising in high purity bile acids, blood group products, complex carbohydrates and other pharmaceutical intermediates and APIs.
Established in 1971 to extract and purify biochemicals from by-products of the New Zealand meat processing industry, NZP has evolved over its ~50 year history into a diversified developer and manufacturer of high value pharmaceutical ingredients with a global raw material procurement and end-product distribution network. Today, NZP is a valued supplier to leading global pharmaceutical manufacturers across Asia, Europe and North America.
For further details, please refer to the press release at this link
ABOUT ICE GROUP
ICE Group is a globally integrated business that produces ingredients for the pharmaceutical industry. Our main product is Ursodeoxycholic Acid (UDCA), a key ingredient in drugs treating liver conditions.
Founded more than sixty years ago, ICE Group is a global leader in bile-related products, with a network of specialist facilities around the world.
ICE’s first plant was opened in Reggio Emilia, Italy (production of Cholic Acid and bile acids derivatives)
BBA Industria Quimica (former Opoterapica) founded in Paranà, Brazil (collection of ox bile and its transformation in raw Cholic Acid)
Acquisition of RPT Texas, USA (collection and concentration of ox bile)
Opening of Arennis in Argentina (collection and concentration of ox bile)
Opening of Walfed Pty in Australia (collection and concentration of ox bile)
Acquisition of PCA, a major manufacturer of UDCA and derivative in Italy
Opening of PBP in Paraguay (collection and concentration of ox bile)
Opening of CVF in Uruguay (collection and concentration of ox bile)
Opening of the Des Moines plant in the USA (collection and concentration of pig bile)
Acquisition of RIAZ in Italy (collection and concentration of ox bile and pig bile)
Opening of Raichem (a 50% Joint Venture started in India)
Raichem becomes a fully owned subsidiary
Advent International acquires ICE Group
ICE Group was established in 1949 by husband-and-wife team Dr Walter and Ida Bartoli. From our humble origins in Northern Italy, we have grown organically and through acquisitions into the company we are today.
We have a vertically integrated model from sourcing to pharma grade production.
Europe, US, Latin America, South
Africa, India, Australia
As well as being the number-one player in the manufacture of UDCA, we also produce a comprehensive range of bile acid derivatives as well as other products we have developed.
Production plants, Italy
Bile extraction plant
and Cholic Acid
Production plant, India
Processing plant, Piacenza, Italy
Processing plants in, Texas & Iowa, USA
Bile extraction plants, Agentina, Uruguay & Paraguay